Speaker illustration

Doctor Francisco Marin

Hospital Universitario Virgen Arrixaca, Murcia (Spain)

Member of:

European Heart Rythm Association

Predictors of adverse clinical outcomes in atrial fibrillation patients with concomitant renal impairment under rivaroxaban therapy

Event: ESC Congress 2021 - The Digital Experience

Topic: Clinical

Session: Atrial fibrillation e-posters

Thumbnail

Impact of potent P2Y12 inhibitors in adverse events reduction in diabetic patients with Acute Coronary Syndromes. An analysis from ACHILLES Registry.

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Insights from acute coronary syndrome registries

Thumbnail

Arrhythmia management and device therapies in endocrine disorders

Event: EHRA 2019

Topic: Pathophysiology and Mechanisms

Session: EHRA expert consensus papers - Key messages 4

Thumbnail

Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events.

Event: ESC CONGRESS 2017

Topic: Biomarkers

Session: Outcomes in atrial fibrillation: room for improvement?

Thumbnail

Dealing with left atrial appendage clot

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Anticoagulation for cardioversion of atrial fibrillation: exploring areas of uncertainty

Thumbnail

The influence of obesity and sleep apnea on atrial fibrillation

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Preventing and delaying atrial fibrillation

Thumbnail

Galentin 3 as marker of interstitial atrial remodeling involved in atrial fibrillation

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Mechanism of arrhythmia in atrial fibrillation . New data on remodelling biomarkers and anti-arrhythmic drugs

Thumbnail

Management of acute coronary syndrome in the elderly: comparison of antiplatelet treatment, revascularization rates and outcome

Event: ESC CONGRESS 2016

Topic: Elderly and cardiovascular diseases

Session: Are we better at managing cardiovascular disease in the elderly?

Thumbnail

Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) biomarker substudy

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Anticoagulation in atrial fibrillation II

Thumbnail

This platform is supported by

logo Novo Nordisk